DXRX — Diaceutics Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsAdventurousSmall CapNeutral

Annual balance sheet for Diaceutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	25.3	19.7	19.8	16.7	12.7
Net Total Accounts Receivable
Net Total Receivables	7.78	9.92	10.4	10.1	15.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.6	30.1	30.9	28	29.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.238	2.13	2.09	1.9	1.68
Net Intangible Assets
Other Long Term Assets
Total Assets	43.5	45	48.3	46.3	48.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.92	2.63	3.75	4.38	7.76
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	3.28	4.36	5.74	5.56	8.76
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	40.2	40.6	42.5	40.8	39.9
Total Liabilities & Shareholders' Equity	43.5	45	48.3	46.3	48.6
Total Common Shares Outstanding